

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.90720595 |
| 2 | protein maturation by protein folding (GO:0022417) | 4.48991858 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.12323285 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.12323285 |
| 5 | viral transcription (GO:0019083) | 4.02847419 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.98159387 |
| 7 | formation of translation preinitiation complex (GO:0001731) | 3.91535189 |
| 8 | translational termination (GO:0006415) | 3.90791567 |
| 9 | membrane raft organization (GO:0031579) | 3.84188150 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 3.74361969 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 3.55056808 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.48674347 |
| 13 | translational elongation (GO:0006414) | 3.46180241 |
| 14 | protein targeting to ER (GO:0045047) | 3.37570701 |
| 15 | regulation of metalloenzyme activity (GO:0048552) | 3.37231944 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 3.35396353 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.34531732 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31953149 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.31328645 |
| 20 | translational initiation (GO:0006413) | 3.26098869 |
| 21 | barbed-end actin filament capping (GO:0051016) | 3.25941002 |
| 22 | pyrimidine nucleoside salvage (GO:0043097) | 3.21898909 |
| 23 | pyrimidine-containing compound salvage (GO:0008655) | 3.21898909 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21550344 |
| 25 | hemidesmosome assembly (GO:0031581) | 3.19151925 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.19063873 |
| 27 | pinocytosis (GO:0006907) | 3.19009764 |
| 28 | DNA strand elongation (GO:0022616) | 3.18730183 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.17544242 |
| 30 | viral life cycle (GO:0019058) | 3.14631502 |
| 31 | protein localization to endoplasmic reticulum (GO:0070972) | 3.13083439 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12603799 |
| 33 | desmosome organization (GO:0002934) | 3.12192507 |
| 34 | telomere maintenance via recombination (GO:0000722) | 3.11182696 |
| 35 | skin morphogenesis (GO:0043589) | 3.11120316 |
| 36 | ribosomal large subunit biogenesis (GO:0042273) | 3.06978693 |
| 37 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.06934006 |
| 38 | cellular protein complex disassembly (GO:0043624) | 2.99520843 |
| 39 | mitotic nuclear envelope reassembly (GO:0007084) | 2.98154918 |
| 40 | nuclear envelope reassembly (GO:0031468) | 2.98154918 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 2.92748360 |
| 42 | mitotic recombination (GO:0006312) | 2.90541835 |
| 43 | DNA unwinding involved in DNA replication (GO:0006268) | 2.90423689 |
| 44 | protein localization to endosome (GO:0036010) | 2.87261040 |
| 45 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86872787 |
| 46 | protein localization to kinetochore (GO:0034501) | 2.85394358 |
| 47 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83029679 |
| 48 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.81090309 |
| 49 | DNA replication initiation (GO:0006270) | 2.79111306 |
| 50 | detection of bacterium (GO:0016045) | 2.76018375 |
| 51 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.75759921 |
| 52 | amyloid precursor protein catabolic process (GO:0042987) | 2.73331285 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 2.72791589 |
| 54 | protein retention in ER lumen (GO:0006621) | 2.71918351 |
| 55 | detection of other organism (GO:0098543) | 2.71214254 |
| 56 | response to peptidoglycan (GO:0032494) | 2.70831577 |
| 57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68135734 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.67110861 |
| 59 | protein complex disassembly (GO:0043241) | 2.66236011 |
| 60 | pentose-phosphate shunt (GO:0006098) | 2.65856157 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.65775764 |
| 62 | IMP biosynthetic process (GO:0006188) | 2.65450356 |
| 63 | DNA replication checkpoint (GO:0000076) | 2.64679096 |
| 64 | hypotonic response (GO:0006971) | 2.62059670 |
| 65 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.61717221 |
| 66 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61036672 |
| 67 | telomere maintenance via telomere lengthening (GO:0010833) | 2.60893389 |
| 68 | cellular response to zinc ion (GO:0071294) | 2.59438552 |
| 69 | leukocyte aggregation (GO:0070486) | 2.58052847 |
| 70 | nucleoside salvage (GO:0043174) | 2.57805115 |
| 71 | mitotic nuclear envelope disassembly (GO:0007077) | 2.57002071 |
| 72 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.56969989 |
| 73 | fibril organization (GO:0097435) | 2.55782715 |
| 74 | B cell mediated immunity (GO:0019724) | 2.50057047 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 2.48718774 |
| 76 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.48532846 |
| 77 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.48173107 |
| 78 | regulation of protein heterodimerization activity (GO:0043497) | 2.47393479 |
| 79 | response to progesterone (GO:0032570) | 2.47064116 |
| 80 | macromolecular complex disassembly (GO:0032984) | 2.46401463 |
| 81 | extracellular fibril organization (GO:0043206) | 2.45988510 |
| 82 | T cell apoptotic process (GO:0070231) | 2.44476091 |
| 83 | type I interferon signaling pathway (GO:0060337) | 2.43357073 |
| 84 | cellular response to type I interferon (GO:0071357) | 2.43357073 |
| 85 | nucleobase biosynthetic process (GO:0046112) | 2.43320031 |
| 86 | IMP metabolic process (GO:0046040) | 2.41740661 |
| 87 | translation (GO:0006412) | 2.41707355 |
| 88 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.40386562 |
| 89 | negative regulation of cell killing (GO:0031342) | 2.39613078 |
| 90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.39613078 |
| 91 | response to type I interferon (GO:0034340) | 2.39103193 |
| 92 | regulation of necrotic cell death (GO:0010939) | 2.38526027 |
| 93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.38295076 |
| 94 | protein localization to chromosome, centromeric region (GO:0071459) | 2.38131911 |
| 95 | glucose catabolic process (GO:0006007) | 2.37841088 |
| 96 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.37260555 |
| 97 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.36787043 |
| 98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36220045 |
| 99 | nuclear envelope disassembly (GO:0051081) | 2.35715500 |
| 100 | membrane disassembly (GO:0030397) | 2.35715500 |
| 101 | regulation of superoxide anion generation (GO:0032928) | 2.35285293 |
| 102 | mitotic metaphase plate congression (GO:0007080) | 2.33187876 |
| 103 | actin filament depolymerization (GO:0030042) | 2.32777329 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30741075 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.30374491 |
| 106 | mRNA catabolic process (GO:0006402) | 2.29841257 |
| 107 | response to interferon-beta (GO:0035456) | 2.28879158 |
| 108 | positive regulation of actin filament depolymerization (GO:0030836) | 2.28223869 |
| 109 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.27960105 |
| 110 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.27742193 |
| 111 | lymphocyte apoptotic process (GO:0070227) | 2.27634740 |
| 112 | regulation of extracellular matrix disassembly (GO:0010715) | 2.26939157 |
| 113 | establishment of viral latency (GO:0019043) | 2.26571628 |
| 114 | protein targeting to membrane (GO:0006612) | 2.25621991 |
| 115 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.25445392 |
| 116 | cellular copper ion homeostasis (GO:0006878) | 2.25134519 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 2.24290270 |
| 118 | RNA catabolic process (GO:0006401) | 2.23470357 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.22850750 |
| 120 | cellular response to virus (GO:0098586) | 2.22702336 |
| 121 | sequestering of actin monomers (GO:0042989) | 2.22634086 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.22034971 |
| 123 | DNA deamination (GO:0045006) | 2.21728523 |
| 124 | purine nucleobase biosynthetic process (GO:0009113) | 2.21553514 |
| 125 | lipoxygenase pathway (GO:0019372) | 2.20804571 |
| 126 | cellular response to arsenic-containing substance (GO:0071243) | 2.20162450 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 2.19698717 |
| 128 | negative regulation of necroptotic process (GO:0060546) | 2.19038952 |
| 129 | regulation of water loss via skin (GO:0033561) | 2.17121323 |
| 130 | detection of external biotic stimulus (GO:0098581) | 2.16518838 |
| 131 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.16124913 |
| 132 | positive regulation of lamellipodium assembly (GO:0010592) | 2.16014457 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.15967668 |
| 134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.15844055 |
| 135 | response to host (GO:0075136) | 2.15844055 |
| 136 | response to host defenses (GO:0052200) | 2.15844055 |
| 137 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.15418723 |
| 138 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.15418723 |
| 139 | establishment of chromosome localization (GO:0051303) | 2.14587417 |
| 140 | CENP-A containing nucleosome assembly (GO:0034080) | 2.14058294 |
| 141 | kinetochore organization (GO:0051383) | 2.14017898 |
| 142 | virion assembly (GO:0019068) | 2.13443023 |
| 143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.13117853 |
| 144 | rRNA processing (GO:0006364) | 2.12913429 |
| 145 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.12147510 |
| 146 | positive regulation of interferon-alpha production (GO:0032727) | 2.12029649 |
| 147 | regulation of podosome assembly (GO:0071801) | 2.11703316 |
| 148 | regulation of gene silencing by RNA (GO:0060966) | 2.11447066 |
| 149 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.11447066 |
| 150 | regulation of gene silencing by miRNA (GO:0060964) | 2.11447066 |
| 151 | pentose metabolic process (GO:0019321) | 2.11161418 |
| 152 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.11077583 |
| 153 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.10873735 |
| 154 | morphogenesis of an endothelium (GO:0003159) | 2.10294883 |
| 155 | endothelial tube morphogenesis (GO:0061154) | 2.10294883 |
| 156 | negative regulation of phagocytosis (GO:0050765) | 2.10283075 |
| 157 | positive regulation of macrophage differentiation (GO:0045651) | 2.10199167 |
| 158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.09402380 |
| 159 | response to interferon-alpha (GO:0035455) | 2.09345302 |
| 160 | membrane protein ectodomain proteolysis (GO:0006509) | 2.09147912 |
| 161 | neutrophil activation (GO:0042119) | 2.08645546 |
| 162 | chromatin remodeling at centromere (GO:0031055) | 2.08221602 |
| 163 | cell cycle G1/S phase transition (GO:0044843) | 2.08029426 |
| 164 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.08029426 |
| 165 | nucleotide salvage (GO:0043173) | 2.07797837 |
| 166 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.07480510 |
| 167 | ribosome biogenesis (GO:0042254) | 2.07448041 |
| 168 | cellular response to dsRNA (GO:0071359) | 2.07083757 |
| 169 | telomere maintenance (GO:0000723) | 2.06908624 |
| 170 | metaphase plate congression (GO:0051310) | 2.06607274 |
| 171 | heterochromatin organization (GO:0070828) | 2.06199034 |
| 172 | nuclear pore organization (GO:0006999) | 2.05949564 |
| 173 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.05754577 |
| 174 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.05754577 |
| 175 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.05754577 |
| 176 | modulation by symbiont of host immune response (GO:0052553) | 2.05754577 |
| 177 | positive regulation by symbiont of host defense response (GO:0052509) | 2.05754577 |
| 178 | modulation by symbiont of host defense response (GO:0052031) | 2.05754577 |
| 179 | myeloid cell homeostasis (GO:0002262) | 2.05582389 |
| 180 | telomere organization (GO:0032200) | 2.04714514 |
| 181 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.04440605 |
| 182 | respiratory burst (GO:0045730) | 2.03974203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.93155203 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.34060336 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18596494 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.09794989 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.00752285 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.93826779 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41942597 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38489686 |
| 9 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.26464937 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18868856 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15212597 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13851847 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.00679130 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.98160651 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96141437 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89895534 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88982763 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88360216 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88118514 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83406561 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81650917 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79875844 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79185221 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.74581028 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71205172 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.69460344 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.69291712 |
| 28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66144358 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65481132 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64654943 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64200475 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.60747222 |
| 33 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60724094 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60683280 |
| 35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.58891528 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57112806 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54464037 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53265328 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52890109 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52470736 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52468333 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51018242 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50694469 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49791951 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49584638 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47970789 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47491125 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46501255 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46001377 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.45415286 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44930824 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43047929 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42796971 |
| 54 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.42331408 |
| 55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.42331408 |
| 56 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40567597 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39675989 |
| 58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38951234 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38595105 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37838375 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36558693 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36035372 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35723456 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35564421 |
| 65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32179634 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31729331 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31444823 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31278027 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28973591 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28449908 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27507230 |
| 72 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24956397 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24060878 |
| 74 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23295385 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23013181 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22562577 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22236852 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22223092 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21096800 |
| 80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19695753 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19221246 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18382240 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.17735029 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17219190 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15474037 |
| 86 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15422946 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14907957 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 1.14253936 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14172742 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14094010 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14065809 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.12372917 |
| 93 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.11840523 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11309511 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11240787 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10353415 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10268354 |
| 98 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10180961 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09950274 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09751158 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09569737 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09391187 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09073312 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08566898 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08520235 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08357380 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08163983 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07809920 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06070187 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05178080 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05035919 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04706474 |
| 113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04537386 |
| 114 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04306885 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04224181 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03647573 |
| 117 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03257156 |
| 118 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03166588 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03115269 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02948502 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02282610 |
| 122 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00961806 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00926642 |
| 124 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00846443 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00058646 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00032710 |
| 127 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98321043 |
| 128 | MYB_26560356_Chip-Seq_TH1_Human | 0.97378912 |
| 129 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97233148 |
| 130 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96876935 |
| 131 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96012689 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95877741 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95639956 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95539164 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95052977 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95052977 |
| 137 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95052977 |
| 138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94180451 |
| 139 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93318473 |
| 140 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92882203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.05987102 |
| 2 | MP0003693_abnormal_embryo_hatching | 2.92656726 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.65852310 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.33083657 |
| 5 | MP0003436_decreased_susceptibility_to | 2.29559776 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.28950056 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.25999635 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.22690534 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.15939614 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.05854280 |
| 11 | MP0002796_impaired_skin_barrier | 2.03661389 |
| 12 | MP0003077_abnormal_cell_cycle | 1.99055863 |
| 13 | MP0003950_abnormal_plasma_membrane | 1.97483985 |
| 14 | MP0010094_abnormal_chromosome_stability | 1.95151715 |
| 15 | MP0009785_altered_susceptibility_to | 1.93034188 |
| 16 | MP0006054_spinal_hemorrhage | 1.91031201 |
| 17 | MP0003111_abnormal_nucleus_morphology | 1.90044559 |
| 18 | MP0005451_abnormal_body_composition | 1.86376395 |
| 19 | MP0009840_abnormal_foam_cell | 1.81973729 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.81714363 |
| 21 | MP0008007_abnormal_cellular_replicative | 1.73940007 |
| 22 | MP0008260_abnormal_autophagy | 1.73691460 |
| 23 | MP0005023_abnormal_wound_healing | 1.73673142 |
| 24 | MP0008057_abnormal_DNA_replication | 1.69768976 |
| 25 | MP0003941_abnormal_skin_development | 1.68867314 |
| 26 | MP0000685_abnormal_immune_system | 1.66208257 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.66090283 |
| 28 | MP0000490_abnormal_crypts_of | 1.65931444 |
| 29 | MP0004510_myositis | 1.64617184 |
| 30 | MP0000858_altered_metastatic_potential | 1.62050442 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.58353639 |
| 32 | MP0003075_altered_response_to | 1.58310509 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.52777611 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.51488509 |
| 35 | MP0002405_respiratory_system_inflammati | 1.49798366 |
| 36 | MP0005387_immune_system_phenotype | 1.48831070 |
| 37 | MP0001790_abnormal_immune_system | 1.48831070 |
| 38 | MP0001853_heart_inflammation | 1.44920173 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.44378097 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.44378097 |
| 41 | MP0003724_increased_susceptibility_to | 1.43975211 |
| 42 | MP0003303_peritoneal_inflammation | 1.43632668 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.43291190 |
| 44 | MP0002419_abnormal_innate_immunity | 1.43265622 |
| 45 | MP0005165_increased_susceptibility_to | 1.42141188 |
| 46 | MP0005025_abnormal_response_to | 1.41827899 |
| 47 | MP0001873_stomach_inflammation | 1.40233073 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.39554002 |
| 49 | MP0009278_abnormal_bone_marrow | 1.38380836 |
| 50 | MP0003448_altered_tumor_morphology | 1.36881223 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.36152898 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.35206026 |
| 53 | MP0010307_abnormal_tumor_latency | 1.34251018 |
| 54 | MP0000343_altered_response_to | 1.32941042 |
| 55 | MP0001800_abnormal_humoral_immune | 1.31688535 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.30103312 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.27544782 |
| 58 | MP0001819_abnormal_immune_cell | 1.27488794 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.26424834 |
| 60 | MP0005257_abnormal_intraocular_pressure | 1.24046279 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.23492727 |
| 62 | MP0005275_abnormal_skin_tensile | 1.22407996 |
| 63 | MP0008932_abnormal_embryonic_tissue | 1.20951106 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.20084672 |
| 65 | MP0002723_abnormal_immune_serum | 1.19773394 |
| 66 | MP0003828_pulmonary_edema | 1.19278234 |
| 67 | MP0000750_abnormal_muscle_regeneration | 1.19239890 |
| 68 | MP0003186_abnormal_redox_activity | 1.18651645 |
| 69 | MP0002398_abnormal_bone_marrow | 1.17063917 |
| 70 | MP0008469_abnormal_protein_level | 1.15126163 |
| 71 | MP0008058_abnormal_DNA_repair | 1.14445878 |
| 72 | MP0005166_decreased_susceptibility_to | 1.13363627 |
| 73 | MP0004947_skin_inflammation | 1.12821144 |
| 74 | MP0005164_abnormal_response_to | 1.12166877 |
| 75 | MP0003763_abnormal_thymus_physiology | 1.11581348 |
| 76 | MP0001730_embryonic_growth_arrest | 1.10634354 |
| 77 | MP0002722_abnormal_immune_system | 1.09248008 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.08739851 |
| 79 | MP0001243_abnormal_dermal_layer | 1.08350985 |
| 80 | MP0003279_aneurysm | 1.08197384 |
| 81 | MP0006082_CNS_inflammation | 1.07457790 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.06731786 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.06104001 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04568746 |
| 85 | MP0005671_abnormal_response_to | 1.03769119 |
| 86 | MP0000716_abnormal_immune_system | 1.03136192 |
| 87 | MP0001851_eye_inflammation | 1.03047496 |
| 88 | MP0001542_abnormal_bone_strength | 1.02631796 |
| 89 | MP0003786_premature_aging | 1.02592222 |
| 90 | MP0002060_abnormal_skin_morphology | 1.02015533 |
| 91 | MP0001958_emphysema | 1.01869488 |
| 92 | MP0003172_abnormal_lysosome_physiology | 1.00627901 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.99744414 |
| 94 | MP0002429_abnormal_blood_cell | 0.99515773 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.98527670 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.97844676 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.96632792 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.95981685 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.95833846 |
| 100 | MP0002086_abnormal_extraembryonic_tissu | 0.95167504 |
| 101 | MP0002933_joint_inflammation | 0.94418357 |
| 102 | MP0003123_paternal_imprinting | 0.93497284 |
| 103 | MP0005390_skeleton_phenotype | 0.93076611 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.91693762 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.91448946 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.91365637 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 0.91273316 |
| 108 | MP0005380_embryogenesis_phenotype | 0.91273316 |
| 109 | MP0009931_abnormal_skin_appearance | 0.91262038 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.91050581 |
| 111 | MP0000313_abnormal_cell_death | 0.90063017 |
| 112 | MP0003984_embryonic_growth_retardation | 0.89670903 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 0.89278281 |
| 114 | MP0010771_integument_phenotype | 0.89168297 |
| 115 | MP0002132_abnormal_respiratory_system | 0.87962780 |
| 116 | MP0002088_abnormal_embryonic_growth/wei | 0.87791738 |
| 117 | MP0001697_abnormal_embryo_size | 0.87148116 |
| 118 | MP0005083_abnormal_biliary_tract | 0.86932073 |
| 119 | MP0009764_decreased_sensitivity_to | 0.85933518 |
| 120 | MP0000516_abnormal_urinary_system | 0.85315844 |
| 121 | MP0005367_renal/urinary_system_phenotyp | 0.85315844 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.85186827 |
| 123 | MP0002006_tumorigenesis | 0.84091857 |
| 124 | MP0003045_fibrosis | 0.84064932 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.81637548 |
| 126 | MP0005330_cardiomyopathy | 0.81098394 |
| 127 | MP0003795_abnormal_bone_structure | 0.80440366 |
| 128 | MP0002080_prenatal_lethality | 0.79830058 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.79659337 |
| 130 | MP0002166_altered_tumor_susceptibility | 0.78924456 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.78894585 |
| 132 | MP0004272_abnormal_basement_membrane | 0.78663259 |
| 133 | MP0003091_abnormal_cell_migration | 0.78611816 |
| 134 | MP0005501_abnormal_skin_physiology | 0.76464026 |
| 135 | MP0004233_abnormal_muscle_weight | 0.73734968 |
| 136 | MP0000749_muscle_degeneration | 0.73254203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 3.77715307 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.64770060 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.50034911 |
| 4 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.20777346 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11250880 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11250880 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11250880 |
| 8 | Amyloidosis (HP:0011034) | 2.99938053 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.93595355 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 2.92021350 |
| 11 | Fatigue (HP:0012378) | 2.84194300 |
| 12 | Myositis (HP:0100614) | 2.74486186 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 2.72110626 |
| 14 | Thrombocytosis (HP:0001894) | 2.70933953 |
| 15 | Alopecia of scalp (HP:0002293) | 2.68184879 |
| 16 | Selective tooth agenesis (HP:0001592) | 2.59298148 |
| 17 | Increased IgE level (HP:0003212) | 2.56235503 |
| 18 | Trismus (HP:0000211) | 2.52543168 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.52403984 |
| 20 | 11 pairs of ribs (HP:0000878) | 2.51274242 |
| 21 | Glucose intolerance (HP:0000833) | 2.48579045 |
| 22 | Axonal loss (HP:0003447) | 2.47147992 |
| 23 | Short nail (HP:0001799) | 2.46160878 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40703254 |
| 25 | Cervical subluxation (HP:0003308) | 2.40488606 |
| 26 | Increased connective tissue (HP:0009025) | 2.40375937 |
| 27 | Thick nail (HP:0001805) | 2.39878206 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.36641390 |
| 29 | Abnormality of the anterior horn cell (HP:0006802) | 2.36265866 |
| 30 | Degeneration of anterior horn cells (HP:0002398) | 2.36265866 |
| 31 | Hypertensive crisis (HP:0100735) | 2.35247849 |
| 32 | Agnosia (HP:0010524) | 2.31874000 |
| 33 | Dysostosis multiplex (HP:0000943) | 2.30915447 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.30784194 |
| 35 | Hepatosplenomegaly (HP:0001433) | 2.27297893 |
| 36 | Entropion (HP:0000621) | 2.24686739 |
| 37 | Aplastic anemia (HP:0001915) | 2.23559276 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.22665842 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.22037489 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.21632053 |
| 41 | Hypokinesia (HP:0002375) | 2.19657810 |
| 42 | Pallor (HP:0000980) | 2.19065769 |
| 43 | Osteolytic defects of the hand bones (HP:0009699) | 2.14549998 |
| 44 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14549998 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.12121825 |
| 46 | Orchitis (HP:0100796) | 2.11564570 |
| 47 | Colon cancer (HP:0003003) | 2.10965602 |
| 48 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.09475877 |
| 49 | Syringomyelia (HP:0003396) | 2.09260493 |
| 50 | Spinal cord lesions (HP:0100561) | 2.09260493 |
| 51 | Vascular calcification (HP:0004934) | 2.09176318 |
| 52 | Fragile skin (HP:0001030) | 2.07761315 |
| 53 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05820812 |
| 54 | Cellulitis (HP:0100658) | 2.03812236 |
| 55 | Birth length less than 3rd percentile (HP:0003561) | 2.03799543 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.03724299 |
| 57 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.03299779 |
| 58 | Vertebral hypoplasia (HP:0008417) | 2.03299779 |
| 59 | Chromsome breakage (HP:0040012) | 2.02573544 |
| 60 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01575421 |
| 61 | Abnormal blistering of the skin (HP:0008066) | 2.01380774 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.00885828 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.00853606 |
| 64 | Pustule (HP:0200039) | 2.00362522 |
| 65 | Rough bone trabeculation (HP:0100670) | 1.97752564 |
| 66 | Spondylolisthesis (HP:0003302) | 1.96756222 |
| 67 | Abnormality of nail color (HP:0100643) | 1.96634979 |
| 68 | Broad face (HP:0000283) | 1.95787474 |
| 69 | Poor head control (HP:0002421) | 1.94835137 |
| 70 | Recurrent viral infections (HP:0004429) | 1.92248684 |
| 71 | Absent thumb (HP:0009777) | 1.91795094 |
| 72 | Cholecystitis (HP:0001082) | 1.91617813 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 1.91617813 |
| 74 | Abnormality of the calcaneus (HP:0008364) | 1.90284512 |
| 75 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90190023 |
| 76 | Ankle contracture (HP:0006466) | 1.89634638 |
| 77 | Metaphyseal cupping (HP:0003021) | 1.89550829 |
| 78 | Orthostatic hypotension (HP:0001278) | 1.89518769 |
| 79 | Elbow flexion contracture (HP:0002987) | 1.88787025 |
| 80 | Prolonged neonatal jaundice (HP:0006579) | 1.88111099 |
| 81 | Achilles tendon contracture (HP:0001771) | 1.86956232 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86405526 |
| 83 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.85873939 |
| 84 | Missing ribs (HP:0000921) | 1.85527390 |
| 85 | Loss of speech (HP:0002371) | 1.85523165 |
| 86 | Impaired platelet aggregation (HP:0003540) | 1.85305651 |
| 87 | Abnormal platelet function (HP:0011869) | 1.85305651 |
| 88 | Erythema (HP:0010783) | 1.85270742 |
| 89 | Obstructive lung disease (HP:0006536) | 1.85109950 |
| 90 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85109950 |
| 91 | IgM deficiency (HP:0002850) | 1.83692411 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 1.83457992 |
| 93 | Atrophic scars (HP:0001075) | 1.83370241 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 1.82989454 |
| 95 | Glossoptosis (HP:0000162) | 1.82455140 |
| 96 | Increased serum ferritin (HP:0003281) | 1.82131165 |
| 97 | Onycholysis (HP:0001806) | 1.81520177 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81245335 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81245335 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81245335 |
| 101 | Generalized amyotrophy (HP:0003700) | 1.81103678 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.80295591 |
| 103 | Skin ulcer (HP:0200042) | 1.80109533 |
| 104 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.79006612 |
| 105 | Polygenic inheritance (HP:0010982) | 1.77461499 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 1.76758335 |
| 107 | Acanthosis nigricans (HP:0000956) | 1.75410843 |
| 108 | Abnormal hemoglobin (HP:0011902) | 1.74154018 |
| 109 | Myocardial infarction (HP:0001658) | 1.73944993 |
| 110 | Hypergammaglobulinemia (HP:0010702) | 1.73402388 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72999146 |
| 112 | Deviation of the thumb (HP:0009603) | 1.72574577 |
| 113 | Myelodysplasia (HP:0002863) | 1.72436426 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72184634 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.72184634 |
| 116 | Macrocytic anemia (HP:0001972) | 1.72147258 |
| 117 | Palmar hyperkeratosis (HP:0010765) | 1.72091009 |
| 118 | Increased density of long bones (HP:0006392) | 1.70783095 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.70762151 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 1.70710752 |
| 121 | Sparse eyelashes (HP:0000653) | 1.70037721 |
| 122 | Muscle fiber atrophy (HP:0100295) | 1.69990844 |
| 123 | Blepharitis (HP:0000498) | 1.69631236 |
| 124 | Difficulty climbing stairs (HP:0003551) | 1.68544646 |
| 125 | Recurrent skin infections (HP:0001581) | 1.66394414 |
| 126 | Joint stiffness (HP:0001387) | 1.65399229 |
| 127 | Stomatitis (HP:0010280) | 1.64583946 |
| 128 | Milia (HP:0001056) | 1.64343245 |
| 129 | Breast hypoplasia (HP:0003187) | 1.64152256 |
| 130 | Oral leukoplakia (HP:0002745) | 1.63786778 |
| 131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.63650800 |
| 132 | Beaking of vertebral bodies (HP:0004568) | 1.63377746 |
| 133 | Fragile nails (HP:0001808) | 1.62978667 |
| 134 | Gingivitis (HP:0000230) | 1.62152978 |
| 135 | Multiple enchondromatosis (HP:0005701) | 1.61168180 |
| 136 | Ulnar deviation of the wrist (HP:0003049) | 1.60411997 |
| 137 | Tracheoesophageal fistula (HP:0002575) | 1.58913251 |
| 138 | Cleft eyelid (HP:0000625) | 1.56586613 |
| 139 | Petechiae (HP:0000967) | 1.56151217 |
| 140 | Premature rupture of membranes (HP:0001788) | 1.54623422 |
| 141 | Abnormal trabecular bone morphology (HP:0100671) | 1.54188213 |
| 142 | Mesomelia (HP:0003027) | 1.53347333 |
| 143 | Cheilitis (HP:0100825) | 1.52952823 |
| 144 | Urticaria (HP:0001025) | 1.51200925 |
| 145 | Carpal bone hypoplasia (HP:0001498) | 1.50779291 |
| 146 | Optic nerve coloboma (HP:0000588) | 1.50223753 |
| 147 | Retrobulbar optic neuritis (HP:0100654) | 1.49931203 |
| 148 | Optic neuritis (HP:0100653) | 1.49931203 |
| 149 | Patellar aplasia (HP:0006443) | 1.49372536 |
| 150 | Osteomyelitis (HP:0002754) | 1.48694878 |
| 151 | Lymphoma (HP:0002665) | 1.48164947 |
| 152 | Nail dystrophy (HP:0008404) | 1.47946865 |
| 153 | Stillbirth (HP:0003826) | 1.47594345 |
| 154 | Meckel diverticulum (HP:0002245) | 1.47565554 |
| 155 | Plantar hyperkeratosis (HP:0007556) | 1.47170397 |
| 156 | Distal lower limb muscle weakness (HP:0009053) | 1.45833050 |
| 157 | Radial bowing (HP:0002986) | 1.45805086 |
| 158 | Spinal muscular atrophy (HP:0007269) | 1.44819409 |
| 159 | Congenital, generalized hypertrichosis (HP:0004540) | 1.44538819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.26227088 |
| 2 | MST1R | 2.83892198 |
| 3 | VRK2 | 2.77673295 |
| 4 | WEE1 | 2.44660719 |
| 5 | TESK1 | 2.22424738 |
| 6 | PIM2 | 2.17859351 |
| 7 | RPS6KA4 | 2.08735057 |
| 8 | ARAF | 2.05667526 |
| 9 | PRPF4B | 2.05239792 |
| 10 | EPHA2 | 2.05164193 |
| 11 | SMG1 | 2.04415715 |
| 12 | BUB1 | 2.01995694 |
| 13 | STK10 | 2.01957069 |
| 14 | MAP3K3 | 2.00663925 |
| 15 | CDC7 | 1.96880681 |
| 16 | MAP4K1 | 1.87261520 |
| 17 | MAP2K3 | 1.78391398 |
| 18 | LRRK2 | 1.77552747 |
| 19 | ERN1 | 1.75281072 |
| 20 | RPS6KB2 | 1.71971658 |
| 21 | TRPM7 | 1.67575594 |
| 22 | LMTK2 | 1.62203032 |
| 23 | TGFBR1 | 1.59175270 |
| 24 | SIK3 | 1.57333302 |
| 25 | TESK2 | 1.57293179 |
| 26 | MOS | 1.53607687 |
| 27 | BRSK2 | 1.52465109 |
| 28 | TAOK2 | 1.49269528 |
| 29 | PAK4 | 1.46452285 |
| 30 | MAP3K12 | 1.45817177 |
| 31 | IRAK4 | 1.44384711 |
| 32 | BLK | 1.43095656 |
| 33 | NEK2 | 1.42704849 |
| 34 | EPHB1 | 1.40959533 |
| 35 | MST4 | 1.36972118 |
| 36 | EIF2AK1 | 1.32827912 |
| 37 | ACVR1B | 1.31306485 |
| 38 | ERBB3 | 1.29513630 |
| 39 | TTN | 1.29423638 |
| 40 | PKN2 | 1.29394502 |
| 41 | NEK9 | 1.27971763 |
| 42 | KIT | 1.27694470 |
| 43 | TBK1 | 1.26709345 |
| 44 | PIM1 | 1.25640237 |
| 45 | MAP3K8 | 1.24074762 |
| 46 | CDK7 | 1.23582423 |
| 47 | MAP3K11 | 1.20879202 |
| 48 | ABL2 | 1.19688145 |
| 49 | EEF2K | 1.18360008 |
| 50 | JAK3 | 1.16708148 |
| 51 | AURKB | 1.16220543 |
| 52 | SIK1 | 1.14519073 |
| 53 | TYK2 | 1.14071815 |
| 54 | FLT3 | 1.12182562 |
| 55 | ZAP70 | 1.11448227 |
| 56 | MAP3K14 | 1.11200732 |
| 57 | KDR | 1.09984850 |
| 58 | STK24 | 1.07818188 |
| 59 | PASK | 1.06137824 |
| 60 | IKBKB | 1.03232697 |
| 61 | MAPKAPK3 | 1.02399675 |
| 62 | MYLK | 1.02142162 |
| 63 | BTK | 1.01304511 |
| 64 | STK4 | 1.00688480 |
| 65 | RIPK4 | 1.00198161 |
| 66 | PLK1 | 0.98433844 |
| 67 | PBK | 0.97844296 |
| 68 | CDK6 | 0.95189605 |
| 69 | DAPK1 | 0.94886404 |
| 70 | TGFBR2 | 0.92514020 |
| 71 | LIMK1 | 0.91828118 |
| 72 | TEC | 0.91679388 |
| 73 | CSK | 0.90427823 |
| 74 | CDK12 | 0.90038590 |
| 75 | MAP3K1 | 0.89649907 |
| 76 | ILK | 0.88645684 |
| 77 | MATK | 0.88216770 |
| 78 | NEK1 | 0.87798085 |
| 79 | EIF2AK3 | 0.87545771 |
| 80 | MET | 0.87124007 |
| 81 | SCYL2 | 0.87088579 |
| 82 | ATR | 0.86653986 |
| 83 | ZAK | 0.84801678 |
| 84 | HIPK2 | 0.84184389 |
| 85 | PLK4 | 0.83603289 |
| 86 | IRAK3 | 0.82508332 |
| 87 | TRIB3 | 0.81411791 |
| 88 | TTK | 0.81364162 |
| 89 | ICK | 0.81161472 |
| 90 | STK16 | 0.81119057 |
| 91 | GRK6 | 0.76170734 |
| 92 | PRKG2 | 0.74414854 |
| 93 | CLK1 | 0.73413756 |
| 94 | MAPK11 | 0.72367111 |
| 95 | BMPR2 | 0.72360569 |
| 96 | CSF1R | 0.71618521 |
| 97 | CHUK | 0.71274975 |
| 98 | CDK4 | 0.65435460 |
| 99 | PTK6 | 0.65169975 |
| 100 | MKNK1 | 0.65168278 |
| 101 | MAPKAPK2 | 0.65057191 |
| 102 | TSSK6 | 0.62210895 |
| 103 | IKBKE | 0.62153961 |
| 104 | VRK1 | 0.61850206 |
| 105 | MAP3K13 | 0.61135996 |
| 106 | MAP3K6 | 0.60484415 |
| 107 | PRKD2 | 0.59018509 |
| 108 | BRAF | 0.58680217 |
| 109 | STK3 | 0.58226986 |
| 110 | PTK2B | 0.56955677 |
| 111 | TAOK1 | 0.56132669 |
| 112 | BMX | 0.55948608 |
| 113 | MAP3K2 | 0.55365469 |
| 114 | RPS6KA6 | 0.55072790 |
| 115 | MAP2K6 | 0.54005238 |
| 116 | BRSK1 | 0.52187389 |
| 117 | EIF2AK2 | 0.51847289 |
| 118 | PAK1 | 0.51026585 |
| 119 | MAP3K10 | 0.50896837 |
| 120 | GRK7 | 0.49574543 |
| 121 | PDK2 | 0.48977797 |
| 122 | MAP3K5 | 0.48822320 |
| 123 | AURKA | 0.48185988 |
| 124 | RPS6KL1 | 0.47332038 |
| 125 | RPS6KC1 | 0.47332038 |
| 126 | CDK8 | 0.47127847 |
| 127 | PLK3 | 0.47005480 |
| 128 | PDPK1 | 0.45784000 |
| 129 | PRKCI | 0.45289734 |
| 130 | JAK1 | 0.45255121 |
| 131 | IRAK2 | 0.45194124 |
| 132 | PTK2 | 0.43364027 |
| 133 | ALK | 0.43300247 |
| 134 | HCK | 0.42395324 |
| 135 | CSNK2A1 | 0.42395292 |
| 136 | EPHB2 | 0.42099367 |
| 137 | MAP2K2 | 0.41122962 |
| 138 | MARK3 | 0.38822661 |
| 139 | CDC42BPA | 0.38556872 |
| 140 | RIPK1 | 0.38060545 |
| 141 | STK38 | 0.37378435 |
| 142 | TXK | 0.37022943 |
| 143 | GSK3A | 0.35860041 |
| 144 | RAF1 | 0.35517967 |
| 145 | ERBB4 | 0.34912533 |
| 146 | BCKDK | 0.34651119 |
| 147 | MELK | 0.33391684 |
| 148 | KSR2 | 0.31543580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.63929897 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.39820620 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.98804624 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.39426914 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.23261479 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03730335 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 1.98835823 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.84321705 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 1.83461441 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 1.83407342 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.81448868 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 1.77957396 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77529813 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74280898 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69698402 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68308925 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62614457 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.61001018 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.59839913 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59067119 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.51796226 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51062737 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46779316 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46161107 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40230981 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.38100894 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32263904 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.29922970 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28345313 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24472745 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23867318 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23237596 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.20456063 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14784463 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13962563 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13932201 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13585741 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12580267 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.12332467 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11637155 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.11466586 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08755209 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07902356 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07445407 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.06124093 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04841757 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.03922749 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03529214 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.02034393 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01971649 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00195409 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99936695 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99840735 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.97588781 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97317392 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96315540 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95964788 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95962856 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.94751572 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94655519 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.93874696 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93739248 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.91229232 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91130118 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90037185 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89234192 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.87948767 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.86871731 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.86220101 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85992692 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84292285 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83110622 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80309897 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.80287011 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80086954 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78646147 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78070035 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77584979 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77176364 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76046878 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75364078 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75220513 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74999368 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74674522 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74195003 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73560726 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72165665 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71791417 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71295075 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71156572 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70367816 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68414285 |
| 93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67795426 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67413438 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66152930 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.65999635 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65619765 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65569467 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.64726067 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64486129 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63799841 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63024217 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62414745 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.61400262 |
| 105 | Protein export_Homo sapiens_hsa03060 | 0.60179058 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59895215 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59786554 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59664577 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58791963 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58641203 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58421989 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57774646 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.56787289 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56428251 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.55043040 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54947748 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53291283 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52891693 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.52781717 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50876878 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50849752 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50578969 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.49355309 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43948127 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43822641 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43218492 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42398113 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41869151 |

